Even though the clinical relevance in the aforementioned cardiovascular danger factor alterations by tirzepatide will likely be assessed within the planned cardiovascular consequence research SURPASS-CVOT ( "kind":"scientific-trial","attrs": "textual content":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-As